WHO suspends hydroxychloroquine trials over safety concerns

A Lancet study leads to a rethink of using the drug to treat coronavirus patients - but an Australian prophylaxis trial will continue

The WHO has suspended its multinational trial of hydroxychloroquine to treat patients with COVID-19, amid growing evidence the drug increases the risk of death.